EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Theranostics in Nuclear Medicine

Deepak Behera, Alexander McEwan

PET Clinics · 2026-07 · 21 (3) · 331-341

DOI: 10.1016/j.cpet.2026.02.006 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift PET Clinics, 2026-07. Verfasst von Deepak Behera und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Bracken Group, Newtown PA, USA; Adaptive Research, San Francisco, CA, USA. Electronic address: dbehera@thebrackengroup.com. Hauptthemen laut MEDLINE: Nuclear Medicine, Radiopharmaceuticals, Theranostic Nanomedicine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Theranostic radiopharmaceutical therapy has moved from niche practice to mainstream oncology, anchored by approvals of lutetium Lu 177 dotatate for somatostatin receptor-positive neuroendocrine tumors and lutetium Lu 177 vipivotide tetraxetan for PSMA-positive prostate cancer. Yet the field's future depends on rigorous clinical trial design, realistic operational planning, and workforce readiness. This review summarizes how theranostics evolved, outlines current regulatory and trial-design yardsticks (including dose optimization and expectations for assessment of late-toxicity), and provides a practical framework for nuclear medicine physicians to assess protocols and prepare their practices for expanding indications and combinations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nuclear MedicineRadiopharmaceuticalsTheranostic NanomedicineHumansNeuroendocrine TumorsRadioisotopesMaleProstatic NeoplasmsLutetium

Stichwörter der Autor:innen

Actinium-225Clinical trial designDosimetryLutetium-177Neuroendocrine tumorProstate cancerRadiopharmaceutical therapyTheranostics

Substanzen

RadiopharmaceuticalsRadioisotopesLutetium

Autor:innen und Institutionen

  • The Bracken Group, Newtown PA, USA; Adaptive Research, San Francisco, CA, USA. Electronic address: dbehera@thebrackengroup.com.
  • The Bracken Group, Newtown PA, USA; University of Alberta, Edmonton, AB, Canada.

Zitieren

APA

Behera, D., & McEwan, A. (2026). Theranostics in Nuclear Medicine. PET Clinics, 21(3), 331-341. https://doi.org/10.1016/j.cpet.2026.02.006

Vancouver

Behera D, McEwan A. Theranostics in Nuclear Medicine. PET Clinics. 2026;21(3):331-341. doi:10.1016/j.cpet.2026.02.006

BibTeX
@article{Behera2026,
  author = {Behera, Deepak and McEwan, Alexander},
  title = {Theranostics in Nuclear Medicine},
  journal = {PET Clinics},
  year = {2026},
  volume = {21},
  number = {3},
  pages = {331--341},
  doi = {10.1016/j.cpet.2026.02.006}
}
Kostenlos starten →